Cancer Support Group

Thursday, Apr 15th

Last update:06:42:40 AM GMT

Home News and Update Year 2010 New Drug Launched to Treat Neutropenia

New Drug Launched to Treat Neutropenia

Indian Express
22 April 2010

GENNOVA Biopharmaceuticals‚ a vertically integrated arm of Emcure Pharmaceuticals Ltd‚ has launched indigenously developed PEGEX (Pegfilgrastim) in India
PEGEX (Pegfilgrastim) is indicated to reduce the duration of neutropenia and also the incidence of febrile neutropenia in patients treated with cytotoxic chemotherap yor treatment of cancer. Neutropenia is the reduction of neutrophils‚ a type of white blood cells.

Arun Khanna‚ Chief Operating Officer of Emcure Pharmaceuticals said “Cytotoxic chemotherapy induced neutropenia is often identified in 10 57% of patients.

PEGEX (Pegfilgrastim) involves just one injection per chemotherapy cycle with similar safety and efficacy profile as filgrastim‚ he said.

Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ‘Fair dealing’ or ‘Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.


This is YOUR sites, so if you have suggestions or feedback on how we can improve it for you, please let us know! We do our best to keep up!

Make a Suggestion
Manthan Award

Link to Aarogya

aarogya logo